ReviewJournal of clinical medicine2023

A JAK Inhibitor for Treatment of Rheumatoid Arthritis: The Baricitinib Experience.

Peter C Taylor et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.